MATTHEW BARDALES: Open Payments
NPI 1700300647 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,696 in 91 payments from 15 companies in 2025. Trend: 2023 $2,242 · 2024 $1,530 · 2025 $1,696
Food & beverage: $1,696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $426 |
| Collegium Pharmaceutical, Inc. | 24 | $380 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $224 |
| Abbott Laboratories | 6 | $205 |
| PFIZER INC. | 4 | $93 |
| Valinor Pharma, LLC | 4 | $68 |
| Medtronic, Inc. | 2 | $55 |
| Forte Bio-Pharma LLC | 3 | $52 |
| IBSA Pharma Inc. | 3 | $46 |
| SCILEX PHARMACEUTICALS INC. | 2 | $34 |
Products named: QULIPTA, Belbuca, RELISTOR, ETERNA, XTAMPZA, NURTEC ODT, UBRELVY, MOVANTIK.
Industry payments across NJ — which companies pay providers there.
